Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Smiseth OA, Khan FH, Inoue K(2026) This editorial refers to "Prognostic value of left atrial stiffness index in adults with repaired coarctation of aorta., by Egbe A et al." in this issue of the journal Eur Heart J Cardiovasc Imaging(in press) DOI 10.1093/ehjci/jeag010, PubMed 41554098
Edvardsen HME(2026) Response to comment on "The role of prescribed opioids in Norwegian overdose deaths in 2005-2021" Eur J Clin Pharmacol, 82(2), 46 DOI 10.1007/s00228-025-03978-5, PubMed 41553491
Salte OB, Hagen RE, Svanevik M, Fagerland MW, Risstad H, Hjelmesæth J, Kristinsson JA, Sandbu R, Mala T(2025) Effect of standard versus long alimentary limb distal Roux-en-Y gastric bypass on weight loss and nutritional outcomes at 10 years in patients with BMI 50-60 kg/m2-a secondary analysis of a randomized clinical trial Br J Surg, 113(1) DOI 10.1093/bjs/znaf285, PubMed 41553109